Global Immunosuppressive Drug Market Research and Forecast, 2018-2023
Immunosuppressive drugs are used for the treatment of end-stage organ replacement or failure. These drugs are anti-rejection drugs used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney. Increasing incidence of chronic ailments and the demand for organ replacement is expected to drive the growth of the market. In addition, growing adoption of tissues engineering in organ transplant also significantly contributing to the market growth. However, high drug cost and a shortage of organ donor for transplant are major restraining factors which may affect the growth of immunosuppressive drug market. Currently, the adoption of newer medication option such as scleroderma treatment and increased use of tissue engineering, which enable in the generation of organs has brought new opportunity to immunosuppressive drug market.
The market is segmented on the basis of application and drug type. On the basis of application, the market is segmented into bone marrow transplant, heart transplant, kidney transplant, liver transplant, and lungs transplant. Kidney transplant and bone marrow transplant is expected to have a considerable share in the market owing to a rise in kidney failure cases. On the basis of drug type, the market is segmented into antibodies, calcineurin inhibitor, antiproliferative agent, MTOR inhibitors and steroids. Calcineurin inhibitor is expected to have the largest market share among all drug type as it is widely used in solid organ transplantation.
Geographically immunosuppressive drug market is divided into North America, Europe, Asia Pacific and Rest of the World. North America region represents considerably the largest market for the immunosuppressive drug in terms of its uses and revenue generation owing to an increase in the prevalence of chronic disease and rising number of transplant procedure. APAC is expected to be the fastest growing region owing to rising government initiatives to reduce the prices of drugs. For instance, in India, National Pharmaceuticals Pricing Authority (NPPA) decided to slash the prices of immunosuppressive drugs by 50% in 2016. Europe is expected to have a moderative growth in immunosuppressive drug market due to an increase in kidney transplant recipients. The major countries that will contribute to the market are the UK, Germany, Spain, France, Italy.
The global players in the immunosuppressive drug market include AbbVie Inc, Actiza Pharmaceutical, Bristol-Myers Squibb company, GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd. The strategy adopted in these companies are continuous development in immunosuppressive solution by (R&D) which made them progress over the past several years. As a result, the market player may offer low-cost, high-value solutions and services for transplant surgery. In April 2018, 4D Molecular Therapeutics (4DMT), expand its 2016 research agreement with F. Hoffmann-La Roche Ltd into a broad long-term strategic partnership to develop and commercialize multiple ophthalmology products.
RESEARCH METHODOLOGY
The market study of global immunosuppressive drug market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Immunosuppressive drug enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
SECONDARY SOURCES INCLUDE:
MARKET SEGMENTATION:
Global Immunosuppressive Drug market is segmented on the basis of regional outlook and following segments:
Global immunosuppressive drug market research and analysis, by application
Global immunosuppressive drug market research and analysis, by drug type
THE REPORT COVERS:
The market is segmented on the basis of application and drug type. On the basis of application, the market is segmented into bone marrow transplant, heart transplant, kidney transplant, liver transplant, and lungs transplant. Kidney transplant and bone marrow transplant is expected to have a considerable share in the market owing to a rise in kidney failure cases. On the basis of drug type, the market is segmented into antibodies, calcineurin inhibitor, antiproliferative agent, MTOR inhibitors and steroids. Calcineurin inhibitor is expected to have the largest market share among all drug type as it is widely used in solid organ transplantation.
Geographically immunosuppressive drug market is divided into North America, Europe, Asia Pacific and Rest of the World. North America region represents considerably the largest market for the immunosuppressive drug in terms of its uses and revenue generation owing to an increase in the prevalence of chronic disease and rising number of transplant procedure. APAC is expected to be the fastest growing region owing to rising government initiatives to reduce the prices of drugs. For instance, in India, National Pharmaceuticals Pricing Authority (NPPA) decided to slash the prices of immunosuppressive drugs by 50% in 2016. Europe is expected to have a moderative growth in immunosuppressive drug market due to an increase in kidney transplant recipients. The major countries that will contribute to the market are the UK, Germany, Spain, France, Italy.
The global players in the immunosuppressive drug market include AbbVie Inc, Actiza Pharmaceutical, Bristol-Myers Squibb company, GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd. The strategy adopted in these companies are continuous development in immunosuppressive solution by (R&D) which made them progress over the past several years. As a result, the market player may offer low-cost, high-value solutions and services for transplant surgery. In April 2018, 4D Molecular Therapeutics (4DMT), expand its 2016 research agreement with F. Hoffmann-La Roche Ltd into a broad long-term strategic partnership to develop and commercialize multiple ophthalmology products.
RESEARCH METHODOLOGY
The market study of global immunosuppressive drug market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, a country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Immunosuppressive drug enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
SECONDARY SOURCES INCLUDE:
- Financial reports of companies involved in the market
- Authentic Public Databases such as the kidney.org, organindia.org, cancer.gov and so on.
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION:
Global Immunosuppressive Drug market is segmented on the basis of regional outlook and following segments:
Global immunosuppressive drug market research and analysis, by application
Global immunosuppressive drug market research and analysis, by drug type
THE REPORT COVERS:
- Comprehensive research methodology of the global immunosuppressive drug market.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global immunosuppressive drug market.
- Insights about market determinants which are stimulating the global immunosuppressive drug market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Growing Incidence of Chronic Diseases Resulting in Organ Failure
3.1.2. Advancement in Organ Transplant & Tissue Engineering
3.1.3. Dominance of Key Market Player
3.1.4. Extensive Clinical Studies And R&D Activities
3.2. Restraint
3.2.1. High Cost of Procedure
3.2.2. Lack of Organs Donors for Transplant
3.3. Opportunity
3.3.1. Newer Medication Option
3.3.2. Increasing Used of Tissue Engineering for Implant Generation
4. MARKET SEGMENTATION
4.1. Global Immunosuppressive Drug Market, By Application
4.1.1. Bone Marrow Transplant
4.1.2. Heart Transplant
4.1.3. Kidney Transplant
4.1.4. Liver Transplant
4.1.5. Lungs Transplant
4.2. Global Immunosuppressive Drug Market, By Drug Type
4.2.1. Antibodies
4.2.2. Calcineurin Inhibitor
4.2.3. Antiproliferative Agent
4.2.4. Motor Inhibitors
4.2.5. Steroids
5. COMPETITIVE LANDSCAPE
5.1. Key Strategies
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of The World
7. COMPANY PROFILES
7.1. AbbVie, Inc.
7.2. Apitope
7.3. Allergan PLC
7.4. Astellas Pharma, Inc.
7.5. BioAgilytix Labs
7.6. Bristol-Myers Squibb
7.7. F. Hoffmann-La Roche Ltd.
7.8. GlaxoSmithKline PLC
7.9. Globela Pharma Pvt. Ltd.
7.10. LGM Pharma
7.11. Novartis AG
7.12. Pfizer, Inc.
7.13. Protalex, Inc.
7.14. Rhizen Pharmaceuticals S.A.
7.15. Sanofi S.A.
7.16. SGPharma
7.17. Taj Pharmaceuticals Ltd
7.18. Topas Therapeutics GmbH
7.19. Veloxis Pharmaceuticals A/S
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Growing Incidence of Chronic Diseases Resulting in Organ Failure
3.1.2. Advancement in Organ Transplant & Tissue Engineering
3.1.3. Dominance of Key Market Player
3.1.4. Extensive Clinical Studies And R&D Activities
3.2. Restraint
3.2.1. High Cost of Procedure
3.2.2. Lack of Organs Donors for Transplant
3.3. Opportunity
3.3.1. Newer Medication Option
3.3.2. Increasing Used of Tissue Engineering for Implant Generation
4. MARKET SEGMENTATION
4.1. Global Immunosuppressive Drug Market, By Application
4.1.1. Bone Marrow Transplant
4.1.2. Heart Transplant
4.1.3. Kidney Transplant
4.1.4. Liver Transplant
4.1.5. Lungs Transplant
4.2. Global Immunosuppressive Drug Market, By Drug Type
4.2.1. Antibodies
4.2.2. Calcineurin Inhibitor
4.2.3. Antiproliferative Agent
4.2.4. Motor Inhibitors
4.2.5. Steroids
5. COMPETITIVE LANDSCAPE
5.1. Key Strategies
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of The World
7. COMPANY PROFILES
7.1. AbbVie, Inc.
7.2. Apitope
7.3. Allergan PLC
7.4. Astellas Pharma, Inc.
7.5. BioAgilytix Labs
7.6. Bristol-Myers Squibb
7.7. F. Hoffmann-La Roche Ltd.
7.8. GlaxoSmithKline PLC
7.9. Globela Pharma Pvt. Ltd.
7.10. LGM Pharma
7.11. Novartis AG
7.12. Pfizer, Inc.
7.13. Protalex, Inc.
7.14. Rhizen Pharmaceuticals S.A.
7.15. Sanofi S.A.
7.16. SGPharma
7.17. Taj Pharmaceuticals Ltd
7.18. Topas Therapeutics GmbH
7.19. Veloxis Pharmaceuticals A/S
LIST OF TABLES
TABLE # 1 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 2 GLOBAL BONE MARROW TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 3 GLOBAL HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 4 GLOBAL KIDNEY TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 5 GLOBAL LIVER TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 6 GLOBAL LUNGS TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 7 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 8 GLOBAL ANTIBODIES MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 9 GLOBAL CALCINEURIN INHIBITOR MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 10 GLOBAL ANTIPROLIFERATIVE AGENT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 11 GLOBAL MTOR INHIBITORS MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 12 GLOBAL STEROIDS MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 13 NORTH AMERICA IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 14 NORTH AMERICA IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 15 NORTH AMERICA SMART PARKING MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 16 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 17 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 18 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 19 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 20 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 21 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 22 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 23 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 1 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 2 GLOBAL BONE MARROW TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 3 GLOBAL HEART TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 4 GLOBAL KIDNEY TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 5 GLOBAL LIVER TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 6 GLOBAL LUNGS TRANSPLANT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 7 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 8 GLOBAL ANTIBODIES MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 9 GLOBAL CALCINEURIN INHIBITOR MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 10 GLOBAL ANTIPROLIFERATIVE AGENT MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 11 GLOBAL MTOR INHIBITORS MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 12 GLOBAL STEROIDS MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
TABLE # 13 NORTH AMERICA IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 14 NORTH AMERICA IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 15 NORTH AMERICA SMART PARKING MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 16 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 17 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 18 EUROPE IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 19 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY 2017-2023($ MILLION)
TABLE # 20 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 21 ASIA PACIFIC IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
TABLE # 22 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023($ MILLION)
TABLE # 23 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET RESEARCH AND ANALYSIS, BY DRUG TYPE 2017-2023($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL IMMUNOSUPPRESSIVE E DRUG MARKET SHARE BY APPLICATION 2017 VS 2023(IN %)
FIGURE # 2 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET SHARE, BY DRUG TYPE 2017 VS 2023(IN %)
FIGURE # 3 UNITED STATES IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023($ MILLION)
FIGURE # 4 CANADA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023($ MILLION)
FIGURE # 5 UK IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 GERMANY IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 7 SPAIN IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 9 ITALY IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 10 REST OF EUROPE IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 11 INDIA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 12 CHINA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 13 JAPAN IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 14 REST OF ASIA PACIFIC REGION IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL IMMUNOSUPPRESSIVE E DRUG MARKET SHARE BY APPLICATION 2017 VS 2023(IN %)
FIGURE # 2 GLOBAL IMMUNOSUPPRESSIVE DRUG MARKET SHARE, BY DRUG TYPE 2017 VS 2023(IN %)
FIGURE # 3 UNITED STATES IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023($ MILLION)
FIGURE # 4 CANADA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023($ MILLION)
FIGURE # 5 UK IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 GERMANY IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 7 SPAIN IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 9 ITALY IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 10 REST OF EUROPE IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 11 INDIA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 12 CHINA IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 13 JAPAN IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
FIGURE # 14 REST OF ASIA PACIFIC REGION IMMUNOSUPPRESSIVE DRUG MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF THE WORLD IMMUNOSUPPRESSIVE DRUG MARKET SIZE,2017-2023 ($ MILLION)
